Myko San medicinal mushroom supplements increase survival in patients with lung cancer

Survival rates in a human cohort patients study done by Myko San in 2009.

Medicinal mushroom extracts have caused no deterioration and improved Quality of Life, overall outcome and survival.

Patients with metastatic non small cell lung adenocarcinoma, stage IV (N=20) had increased survival when mycotherapy using Myko San extracts was used (blue line), than in patients only receiving standard therapy (red line).

The results were published at the 5th International Medicinal Mushroom Conference in Nantong, China, in 2009.